Pharmac has opened consultation to fund Keytruda for five cancer indications (Triple Negative Breast, Head and Neck, Colorectal, Bladder and Hodgkin-Lymphoma) as well as Opdivo for Kidney cancer. Pharmac is looking to fund Keytruda from October and ...
